Molecular farming in plants is an emerging platform for the production of pharmaceutical
proteins, and host species such as tobacco are now becoming competitive with …

Purpose This study aimed to systematically review and critically appraise cost-effectiveness
studies on Brentuximab vedotin (BV) in patients with Hodgkin lymphoma (HL). Methods The …

Fundamentos: Los contratos de riesgo compartido (CRC) presentan un novedoso
instrumento de gestión sanitaria que condiciona el pago a la compañía farmacéutica …

Introduction A systematic literature review was conducted to understand disease burden in
patients with relapsed/refractory classical Hodgkin lymphoma (R/R cHL). Areas covered …

Cancer care in the United States faces a perfect storm: an aging population and expected
increased cancer incidence, growing numbers of cancer survivors with ongoing care needs …

Background Relapsed or refractory classic Hodgkin lymphoma (RRcHL) associates with
poor prognosis and heavy disease burden to patients. This study evaluated the cost …

Introduction: Novel immunotherapeutic agents (eg monoclonal antibodies, antibody-drug
conjugates, bispecific T-cell engagers) as treatment options for hematologic malignancies …

Treatment of Hodgkin lymphoma (HL) has evolved with risk‐stratified therapy based on PET‐
CT scan at multiple timepoints. In a resource constraint setting even a single PET‐CT scan …

Purpose Cancer treatment is a significant driver of healthcare costs worldwide, however, the
economic impact of treating patients with anti-neoplastic agents is poorly elucidated. We …

Anaplastic diffuse large B-cell lymphoma (A-DLBCL) is a mysterious and rare disease, its
histopathological features have not been fully clari ed toaday. This paper provides a case in …